PTC Therapeutics Inc (NASDAQ:PTCT) entered into a strategic financing collaboration with Blackstone Inc (NYSE:BX). As part of the collaboration, Blackstone Life Sciences and…
Litigation with Sabby and Another Institutional Shareholder Settled
Kiromic BioPharma, Inc. (NASDAQ:KRBP) ("Kiromic" or the "Company"), a clinical-stage fully-integrated biotherapeutics company
Better Choice Company Inc. (NYSE:BTTR) (the "Company" or "Better Choice"), a pet health and wellness company, today announced that it has successfully extended and upsized the Company's existing
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Taysha Gene Therapies, Inc. (NASDAQ: TSHA, CEO: RA Session II, "Taysha") today announced a strategic investment to support the advancement of Taysha's adeno-associated virus (AAV) gene therapy development programs for the treatment of Rett syndrome and GAN.
Barings, one of the world's leading investment managers, announced today that it will provide $11.5 million in permanent financing for Euclid Glenmore Apartments, an affordable multifamily housing
US and German-based HMNC Brain Health (HMNC Holding GmbH), a clinical stage biopharma company pioneering precision psychiatry, has raised nearly $14 million (EUR 14.3 million) in the closing of the first of two expected funding series, bringing the total capital raised to date to over $41 million (EUR 42.3 million.) The second closing of this round would be completed by the end
Battered Credit Suisse Group AG (NYSE: CS) recently launched a process to sell its U.S. asset management arm, dubbed Credit Suisse Asset Management (CSAM).